Focus on Pathways: Targeting the CSF-1R Pathway in Graft-vs-Host Disease - Episode 4
Clinical Scenario and Perspectives on the Evolving Treatment Landscape in GVHD
Dr. Hannah Choe discusses a clinical scenario of a patient with GVHD who has progressed after multiple lines of treatment. She explores how the availability of CSF-1R inhibitors could fit into the evolving treatment landscape for managing this difficult-to-treat patient population. Dr. Choe provides her perspectives on the potential role and clinical implications of targeting this pathway as an emerging therapeutic approach for GVHD.
Related Content:
